Freenome Website, Blog & Press Pages

Freenome Website, Blog & Press Pages - aVenture

Freenome - Library

freenome.comCrawled Oct 15, 2026

Press

6 pages

Freenome Announces CEO Transition/newsroom/freenome-announces-ceo-transition
The Board of Directors established an interim Office of the CEO and began searching for a successor to lead the company.
Freenome Announces Topline Results for PREEMPT CRC to Validate the First Version of its Blood-Based Test for the Early Detection of Colorectal Cancer/newsroom/freenome-announces-topline-results-for-preempt-crc-to-validate-the-first-version-of-its-blood-based-test-for-the-early-detection-of-colorectal-cancer
The PREEMPT study met all primary endpoints, with 79.2% sensitivity for colorectal cancer (CRC) and 91.5% specificity for non-advanced colorectal neoplasia.
Freenome Appoints Linh H. Le as Chief Financial Officer/newsroom/freenome-appoints-linh-h-le-as-chief-financial-officer
A diagnostics executive has expertise in financial strategy and operational infrastructure development across the diagnostics and Medtech industries.
Freenome Names Aaron Elliott, Ph.D., as Chief Executive Officer to Lead the Company’s Next Chapter of Commercial Growth and Product Innovation/newsroom/freenome-names-aaron-elliott-as-chief-executive-officer
An industry professional brings specialized experience to advance Freenome’s screening blood tests for colorectal cancer, lung cancer, and additional indications.

Careers & Hiring

3 pages

Careers/careers
Freenome offers company benefits and current job openings.
Jobs/jobs
The company does not accept unsolicited resumes or biographies from agencies.
Notice/careers/notice
The notice warns candidates about recruiting scams.

Contact

1 page

Homepage

1 page

Homepage/
Freenome is a private biotech company focused on developing blood tests to detect cancer early and make screening accessible for everyone.

Privacy

1 page

Privacy notice/privacy-policy
Freenome Holdings, Inc. says it is committed to protecting personal information.

Coverage

5 items

freenomegithub.com/freenome
GitHubRepository owner
FDA Grants Breakthrough Device Designation to Freenome's Blood-Based SimpleScreen Lung Cancer Screening Testfreenome.com/newsroom/fda-grants-breakthrough-device-designation-to-freenomes-blood-based-simplescreen-lung-cancer-screening-test/
Freenome’s investigational blood-based lung cancer screening test receives FDA Breakthrough Device Designation for high-risk adults who do not participate in recommended screening. The company says the test is intended to complement low-dose CT follow-up and remains in clinical evaluation currently.
Aug 2026 · FreenomeNews article
FDA Approves Freenome's SimpleScreen CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.freenome.com/newsroom/fda-approves-freenomes-simplescreen-crc/
Freenome announces FDA approval of SimpleScreen CRC, a blood-based colorectal cancer screening test for average-risk adults aged 45 and older. Abbott is named the test's exclusive United States commercializer, while Freenome says approval was supported by the PREEMPT CRC study and included a milestone payment tied to approval.
Jul 2026 · FreenomeNews article
Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detectionfreenome.com/newsroom/freenome-debuts-as-a-publicly-traded-company-focused-on-blood-based-early-cancer-detection/
Freenome completes its combination with Perceptive Capital Solutions Corp and begins trading on Nasdaq under ticker FRNM. The transaction provides approximately $310 million in gross proceeds to support its screening portfolio, multiomics platform, and commercial infrastructure.
Jul 2026 · FreenomeNews article